ong-term efficacy and safety of microwave ablation in the treatment of mild axillary hidradenitis suppurativa: a randomized intra-patient controlled trial

Completed

• Conditions: acne ectopica; acne inversa; 10014982

• Registration Number: NL-OMON44256
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Key inclusion criteria:
- Adult (* 18 years old) patients suffering from HS;
- Minimum of 3 AN-count located in each axilla;
- Maximum of 5 AN-count located in each axilla.

Exclusion Criteria

Key exclusion criteria:
- >1 abscess or draining fistula per axillary area;
- AN-count * 5 in other regions than the axillary area;
- Surgical scars covering more than 25% of each individual axillary area;
- Previous successful use of laser or light therapy for hair removal in the axillary area;
- Use of botulinum toxin injections 6 months prior to randomization.
- Pregnancy (at time of treatment)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical efficacy: Hidradenitis Suppurativa Clinical Response (HiSCR 50%),<br /><br>based on the lesion count (AN count). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- PROMs: number of flares, numerical rating scale on pain and itch, patient<br /><br>satisfaction;<br /><br>- Average number of hair containing follicles (dermatoscopy);<br /><br>- The extent of sweat production (starch-iodine test);<br /><br>- Safety parameters (adverse events).</p><br>